Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
FASEB J. 2024 May 31;38(10):e23683. doi: 10.1096/fj.202400078R.
Mesenchymal stromal cells (MSCs) have been shown to modulate the function of various subsets of T cells such as naïve CD4 T cells and IFNγCD4 Th1 cells; however, mechanisms underlying this regulation have not been fully deciphered. Our in vitro culture assays demonstrate that MSCs suppress the activation and function of CD4 T cells by secreting interleukin 11, and neutralization of IL11 abrogates MSC-mediated suppression of CD4 T cell function. Moreover, delayed-type, exogenous supplementation of IL11 significantly suppressed IFNγ expression by Th1 cells. Th1 and CD8 cells play central roles in T cell-mediated tissue damage. Using a murine model of hypersensitivity response to study T cell-mediated tissue damage, we show that silencing IL11 in MSCs significantly abates the capacity of MSCs to suppress the generation of IFNγ-secreting CD4 and CD8 cells, failing to prevent T cell-mediated tissue inflammation and tissue damage.
间充质基质细胞(MSCs)已被证明可调节各种 T 细胞亚群的功能,如幼稚 CD4 T 细胞和 IFNγCD4 Th1 细胞;然而,这种调节的机制尚未完全破译。我们的体外培养实验表明,MSCs 通过分泌白细胞介素 11 来抑制 CD4 T 细胞的激活和功能,中和 IL11 可消除 MSC 对 CD4 T 细胞功能的抑制。此外,外源性补充白细胞介素 11 的迟发型显著抑制了 Th1 细胞 IFNγ 的表达。Th1 和 CD8 细胞在 T 细胞介导的组织损伤中起核心作用。使用过敏反应的小鼠模型来研究 T 细胞介导的组织损伤,我们发现沉默 MSCs 中的白细胞介素 11 可显著降低 MSCs 抑制 IFNγ 分泌的 CD4 和 CD8 细胞产生的能力,无法防止 T 细胞介导的组织炎症和组织损伤。